© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Epilepsy
The NeurologyLive epilepsy clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to epilepsy and related epileptic conditions, including Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex, focal seizures, nonmotor seizures, and more.
Nomograms Assist in Predicting Memory Decline in Epilepsy Post-Temporal Lobe Resection
July 24, 2021
Article
Investigators observed declines in delayed verbal recall in 20% to 30% of individuals who underwent a dominant temporal lobe resection for treatment of epilepsy.
Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke
July 24, 2021
Video
Neurology News Network for the week ending July 24, 2021.
NeurologyLive Friday 5 — July 23, 2021
July 23, 2021
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 23, 2021.
FDA Approves Senza System for Chronic Pain Associated With Diabetic Neuropathy
July 22, 2021
Article
Basis for the approval was the SENZA-PDN randomized controlled trial, which showed the system’s ability to substantially sustain pain relief and improve health-related quality of life.
Cenobamate Demonstrates High Rates of Long-Term Retention in Refractory Epilepsy
July 22, 2021
Article
Treatment retention with cenobamate ranged from 73% of patients at 1 year to 59% of patients at 6 years.
Therapies for Children and Adults with Dravet Syndrome
July 19, 2021
Video
The panelists discuss the possibility of treating Dravet syndrome in older children and adults and the effects if the therapies were effective.
Looking to the Future of Dravet Syndrome Therapies
July 19, 2021
Video
The panel discusses future gene therapies in development for Dravet syndrome.
This Week on NeurologyLive — July 19, 2021
July 19, 2021
Article
Here's what is coming soon to NeurologyLive.
Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced
July 17, 2021
Video
Neurology News Network for the week ending July 17, 2021.
NeurologyLive Friday 5 — July 16, 2021
July 16, 2021
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 15, 2021.